A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

June 30, 2006

Conditions

Patients With Pace Makers But no Evidence of Ischemic Heart Disease

Interventions

DRUG

GTN

DRUG

Moxifloxacin

Trial Locations (6)

Pfizer Investigational Site, Bruxelles (Brussels)

Pfizer Investigational Site, Glasgow

Pfizer Investigational Site, Leicester

Pfizer Investigational Site, Liverpool

Pfizer Investigational Site, London

Pfizer Investigational Site, Manchester